Emperra specializes in digital health solutions for people living with diabetes. The company has appointed Mr. Bent Johnsen as Managing Director and CEO. 

Mr. Johnsen, who is a Danish national, has an extensive international career in the health care sector and has lived and worked in multiple countries within Europe and the USA.  

He has held several executive leadership positions within the field of diabetes working for a global insulin manufacturing company as well as with other global medical device companies.

Furthermore, Mr. Johnsen has comprehensive experience in working with smaller growth companies and has formerly served as both CEO and a board member for medical device companies.

His solid international management experience is seen as very valuable at this stage where Emperra is progressing rapidly to make the innovative digital health diabetes management system ESYSTA broadly available both in Germany and internationally.

Mr. Johnsen is very excited about the ESYSTA solution and its benefits for patients, doctors and nurses.

Mr. Johnsen is succeeding Dr. Christian Krey as CEO, who has decided to pursue new opportunities and will be leaving the company by the end of June 2017. The Board of Emperra is thankful to Dr. Krey for his contribution in launching ESYSTA, the world's first digitally connected insulin pen and blood glucose monitoring system in the German market.